TOCQUEVILLE ASSET MANAGEMENT L.P.
Position in PBYI — Puma Biotechnology, Inc.
CIK 883961
New York, NY
Position in PBYI
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$107,960
+$25,146 QoQ
Shares Held
13,312
+2.7% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 160 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TOCQUEVILLE ASSET MANAGEMENT L.P. holds $29,586,127 across 12 Biotechnology names. PBYI ranks #12 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
251,215 | $19,918,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,315 | $2,067,035 | |
| 3 | CSBR |
Champions Oncology, Inc.
|
295,658 | $1,821,253 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
19,650 | $1,463,532 | |
| 5 | MGTX |
MeiraGTx Holdings plc
|
77,700 | $1,049,727 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
31,250 | $1,043,437 | |
| 7 | IMMX |
Immix Biopharma, Inc.
|
88,550 | $912,950 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
2,300 | $562,971 |
All Filings in PBYI
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $107,960 | 13,312 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $82,814 | 12,960 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||